SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Aventus Network

Aventus Network ($AVT.X) is trending as traders discuss its potential for a breakout, pointing to its strong chart setup and real-world partnerships. Community members are drawn to its low market cap, integration with Polkadot, and enterprise use cases, suggesting it may be undervalued. Volume is a key point of focus, as traders anticipate it could drive significant price movement.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MLTX is trending due to recent Phase 2 trial data for its skin drug, sonelokimab, showing positive results in hidradenitis suppurativa. The community is discussing the drug's efficacy compared to competitors and speculating about a potential buyout, possibly by Merck, despite a higher-than-expected placebo response in one trial. Some traders are wary of the trial data, while others see long-term potential.

Merus NV is a clinical-stage immuno-oncology company, which engages in the discovery and development of bispecific antibody therapeutics. Its pipeline includes Biclonics for solid and hematological tumors. The company was founded by Ton Logtenberg and Hennie Hoogenboom on June 16, 2003 and is headquartered in Utrecht, the Netherlands.

Merus N.V

Recent buzz around Merus (MRUS) is driven by buyout rumors, with Genmab reportedly leading the acquisition race, exciting retail traders. The community is also discussing Barclays' initiation of an Overweight rating with a $112 price target. Some traders are highlighting the potential of Merus's pipeline and multispecific antibody platform.

Applied Optoelectronics, Inc. engages in the design and manufacture of optical communications products. Its products include optical devices, such as laser diodes, photodiodes, related modules and circuitry, and equipment for applications in fiber-to-the-home, cable television, point to point communications, and wireless. The company was founded by Chih Hsiang Lin on February 28, 1997 and is headquartered in Sugar Land, TX.

Applied Optoelectronics Inc

Applied Optoelectronics ($AAOI) is trending due to its announcement of the first volume shipment of data center transceivers to a major hyperscale customer, signaling a re-engagement after several years. Bullish sentiment is fueled by expectations of significant business opportunities and increased demand for AI infrastructure, although some analysts remain cautious. The community is actively discussing potential upside, with some expecting a return to higher price levels amid speculation about customer identity and potential for a short squeeze.

Enanta Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery and development of small molecule drugs for the treatment of viral infections and liver diseases. It produces clinical candidates which targets respiratory syncytial virus (RSV), hepatitis B virus (HBV), and non-alcoholic steatohepatitis (NASH) diseases. The firm also conducts research in human metapneumovirus (hMPV) and SARS-CoV-2 (COVID-19). The company was founded by Peter O. Kliem Martin Karplus, James Hogle, Gerard Wagner, Peter M. Howley, and Gregory L. Verdine in 1995 and is headquartered in Watertown, MA.

Enanta Pharmaceuticals Inc

Enanta Pharmaceuticals is trending due to anticipation surrounding topline results from its Phase 2b study of zelicapavir for RSV in high-risk adults, expected soon. Community members are closely watching for a potential catalyst, with some speculating on significant price movement based on trial outcomes. Bullish sentiment is building as the company's pipeline and potential market position are being discussed.

Cipher Mining, Inc. operates as a Bitcoin mining ecosystem in the United States. The firm is developing a cryptocurrency business. The company was founded in 2021 and is headquartered in New York, NY.

Cipher Mining Inc

Despite a recent offering, Cipher Mining is trending as investors see a bullish signal due to its partnership with Google and expansion into high-performance computing. The community is actively discussing the potential for significant growth, especially with the zero-interest funding deal and capped call protections against dilution. Some investors believe Cipher Mining is undervalued, positioning itself as a key player in AI infrastructure rather than just Bitcoin mining.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is trending following positive phase 3 trial results for its oral Wegovy pill, showing significant weight loss, which could broaden its market appeal; the community is weighing its potential against competitor Eli Lilly. Community members are also digesting news of job cuts impacting the US obesity education team amid an increasingly competitive GLP-1 market.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

CELH is trending amid discussions around growth prospects, potential analyst upgrades, and a possible climb to new highs, with the community actively debating entry points and year-end targets. Bullish sentiment is fueled by the Pepsi distribution partnership and Alani Nu acquisition, while some express concerns about the stock's volatility and recent price action. Discussions also involve potential catalysts, technical analysis, and the beverage's increasing presence in stores.

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is trending as a crypto emphasizing community, culture, and freedom within the cannabis space. Community members highlight Weedcoin as more than just a token, but a movement to connect people and ideas. With the hashtags #Weedcoin #CryptoCulture #Growth, the community is focused on building a positive and inclusive environment.

KKR & Co., Inc. operates as an investment firm. It offers alternative asset management as well as capital markets and insurance solutions. The firm's business segments include Asset Management and Insurance Business. The Asset Management segment engages in providing private equity, real assets, credit and liquid strategies, capital markets, and principal activities. The Insurance Business segment offers retirement, life insurance and reinsurance solutions to clients across individual and institutional markets. The company was founded by Henry Kravis, George R. Roberts, and Jerome Kholberg on May 1, 1976 and is headquartered in New York, NY.

KKR & Co. Inc

KKR & Co. Inc.

KKR is trending due to a mix of news, including a TotalEnergies solar portfolio acquisition and a stake in Sempra Infrastructure. Community members are also actively discussing unusual options activity, particularly call sweeps, suggesting bullish sentiment. Additionally, KKR's potential involvement in a TikTok deal and broader discussions around alternative asset management are contributing to the stock's current buzz.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Cleveland-Cliffs (CLF) Rises Higher Than Market: Key Facts

In the closing of the recent trading day, Cleveland-Cliffs (CLF) stood at $11.75, denoting a +1.21% move from the preceding trading day.

Is Trending Stock Cleveland-Cliffs Inc. (CLF) a Buy Now?

Recently, Zacks.com users have been paying close attention to Cleveland-Cliffs (CLF). This makes it worthwhile to examine what the stock has in store.

Here's Why Cleveland-Cliffs (CLF) Fell More Than Broader Market

In the closing of the recent trading day, Cleveland-Cliffs (CLF) stood at $11.74, denoting a -1.3% move from the preceding trading day.

Cleveland-Cliffs (CLF) Exceeds Market Returns: Some Facts to Consider

Cleveland-Cliffs (CLF) concluded the recent trading session at $11.89, signifying a +1.8% move from its prior day's close.

Cleveland-Cliffs (CLF) Stock Sinks As Market Gains: What You Should Know

In the latest trading session, Cleveland-Cliffs (CLF) closed at $10.81, marking a -1.91% move from the previous day.

Is Most-Watched Stock Cleveland-Cliffs Inc. (CLF) Worth Betting on Now?

Nucor Gains 20% in 3 Months: How Should Investors Play the Stock?

Nucor stock has jumped 20% in three months as growth projects and acquisitions boost momentum despite the recent retreat in steel prices. 

Nucor's Steel Mills Shipments Climb: Can Margins Hold in Q3?

NUE posts higher Q2 steel mill shipments and utilization gains, but margin pressures loom for Q3 despite firm demand.

Cleveland-Cliffs Inc. (CLF) is Attracting Investor Attention: Here is What You Should Know  

Cleveland-Cliffs (CLF) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Cleveland-Cliffs (CLF) Down 7.9% Since Last Earnings Report: Can It Rebound?

Cleveland-Cliffs (CLF) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Cleveland-Cliffs, Inc. is a flat-rolled steel company, which engages in provision of iron ore pellets to the North American steel industry. It focuses on the production of metallic and coke, iron making, steelmaking, rolling and finishing, and downstream tubular components, stamping, and tooling. The company was founded in 1847 and is headquartered in Cleveland, OH.

Cleveland-Cliffs Inc

Will the U.S. government shut down in 2025? 
 
*Powered by Polymarket

Current Price	$12.36
Prev Close	$12.07
Open	$12.07
Dividend Yield	0.00%
50-Day Moving Average	$10.79
Beta	1.60
Avg. Volume	16.99M
PE Ratio	-3.62

52-Week High	$14.34
52-Week Low	$5.63
Market Capitalization	$6.12B
EPS (Annual)	-$1.57
Price to Book	1.05
Revenue Per Employee	$639,500.00
Enterprise Value/EBITDA	N/A

CLF
Cleveland-Cliffs Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest CLF News

CLF Cleveland-Cliffs Inc